Lv11
80 积分 2022-11-24 加入
Isoleucine, Leucine and Their Role in Experimental Models of Bladder Carcinogenesis
3小时前
已关闭
Efficacy of Brexpiprazole Across Agitation Behaviors in Alzheimer's Disease, Including Impact on Caregivers, Analyzed Using the Neuropsychiatric Inventory: A Post Hoc Pooled Analysis of Randomized, Fixed-Dose, Placebo-Controlled Trials
3天前
已完结
Differential Outcomes of Placebo Treatment Across 9 Psychiatric Disorders
9天前
已完结
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
2个月前
已完结
The advent of Alzheimer treatments will change the trajectory of human aging
2个月前
已完结
AZD0780, the first oral small molecule PCSK9 inhibitor for the treatment of hypercholesterolemia: Results from a randomized, single-blind, placebo-controlled phase 1 trial
2个月前
已完结
ANXIOLYTICS: Origins, drug discovery, and mechanisms
2个月前
已完结
The Main Targets Involved in Neuroprotection for the Treatment of Alzheimer’s Disease and Parkinson Disease
2个月前
已完结
Population‐Based Characterization of the Pharmacokinetics and Food Effect of ANAVEX3‐71, a Novel Sigma‐1 Receptor and Allosteric M1 Muscarinic Receptor Agonist in Development for Treatment of Frontotemporal Dementia, Schizophrenia, and Alzheimer Disease
2个月前
已完结
Anti-amnesic and neuroprotective potentials of the mixed muscarinic receptor/sigma1 (σ1) ligand ANAVEX2-73, a novel aminotetrahydrofuran derivative
2个月前
已完结
皖公网安备34019202002308
